Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Activated Carbon Fiber Market – Growth, Trends, and Forecast (2019 – 2024)
| Chemical & Materials | Published by: Mordor Intelligence | Market: |
| 95 pages | Published: 28-06-2019 |
- Chemical & Materials
- Mordor Intelligence
- 95 pages
- Published: 28-06-2019
Market Overview
The market for activated carbon fiber is anticipated to register a CAGR of more than 3.30% during the forecast period, 2019-2024. Activated carbon fiber is commonly produced from carbon fiber by the pyrolysis of carbonaceous materials, like polyacrylonitrile (PAN), coal tar pitch and petrol pitch, rayon (majorly viscose), and biomass (primarily jute, coconut fiber, oil palm, and cellulose), among others.
Increasing environmental concerns related to air and water pollution, coupled with activated carbon fiber’s superior properties in comparison to that of powdered activated carbons (PAC) and granular activated carbons (GAC), are expected to drive the demand for the market during the forecast period.
Concerns related to its raw materials, such as synthetic fiber (which is non-degradable and tends to bind with molecules of harmful chemical pollutants in wastewater), and flame retardants and pesticides will probably affect the market’s growth. Additionally, its production causes irreversible damage to the environment due to emission of harmful pollutants into the environment. Such factors are likely to hinder the growth of the market.
Rising demand from the protective clothing industry and growing applications in natural gas and in storage of methane are projected to act as opportunities of growth for the market in future.
Key Market Trends
Increasing Demand from the Protective Clothing Industry
Various adsorbent materials are used in the production of chemical protective clothing, including activated carbon powder, sphere or fabric. It is also used in other industries, such as firefighting, mining, medical, construction, etc., as well as other manufacturing industries.
In the production of chemical protective suits, these adsorbent materials are bonded on base fabrics using a polymeric adhesive, followed by another layer of nonwoven fabrics, using adhesive or hot melt techniques. Furthermore, fabrication of chemical protective suits are carried out to produce a complete individual protective suit. However, powder-activated carbon or charcoal-based chemical protective suits are not compatible for laundry, due to which, a suit cannot be reused. The activated carbon spheres (ACS)-based chemical protective suits can be used, even after multiple laundries. However, it has certain limitations.
ACF-based chemical protective suits are comfortable, light in weight, and they sustain even after multiple laundries and address the limits of ACS-based suits. Owing to these factors, the demand for ACF has been increasing in the protective clothing industry. The healthcare industry has been witnessing a strong growth in the Asia-Pacific and Middle Eastern regions, with new investments coming in for the development of the industry. With this, the demand for protective clothing for medical application is expected to increase in the coming years.
With an increase in the number of soldiers every year and the need to provide protective suits for them, a further demand for protective clothing is witnessed by the market.
All the afore-mentioned factors are expected to drive the market during the forecast period.
North America to Dominate the Market
The United States is the world’s largest economy in the world. GDP growth rate of the country is expected to slow down to 2.3% in year 2019 from 3% in 2018. According to CDC, almost 15% of the people in the country suffer with chronic kidney disease (CKD). The number of patients has been on rise since the past few years. This scenario, is turn, boosting the demand for activated carbon fiber in the dialysis applications. Furthermore, increasing developments in chemical industry in the country is, in turn, boosting the demand for activated carbon fiber. According to the EIA’s annual refinery capacity report, the United States’ operable atmospheric crude distillation capacity reached 18.6 million barrels per calendar day (b/cd), in January 2018, registering a decrease of 0.1%, as compared to the beginning of 2017. Another major industry driving the demand for activated carbon fiber is the chemical industry. For instance, the United States is the world’s third-largest producer of polypropylene. Furthermore, rising investments in the chemical industry in the country is likely to further boost the demand for activated carbon fibers.
Competitive Landscape
The activated carbon fiber market is partially consolidated. In terms of market share, few of the major players currently dominate the market. Key players in the market include Anshan Sinocarb Carbon Fibers Co. Ltd, Hangzhou Nature Technology Co. Ltd, Awa Paper & Technological Company Inc., Evertech Envisafe Ecology Co. Ltd, HP Materials Solutions Inc., Jiangsu Tongkang Activated Carbon Fiber Co. Ltd, and Osaka Gas Chemicals Co. Ltd, among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Increasing Environmental Concerns Related to Air and Water Pollution
4.1.2 Superior Properties of Activated Carbon Fiber
4.2 Restraints
4.2.1 Concerns Related to Raw Materials
4.3 Industry Value Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition
5 MARKET SEGMENTATION
5.1 Raw Material
5.1.1 Synthetic
5.1.1.1 Pitch-based
5.1.1.2 PAN-based
5.1.1.3 Phenolic-based
5.1.1.4 Viscose-based
5.1.1.5 Other Synthetics
5.1.2 Natural
5.2 Application
5.2.1 Purification
5.2.2 Chemical Separation and Catalysis
5.2.3 Protective Clothing
5.2.4 Medical
5.2.5 Super Capacitors
5.2.6 Other Applications
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 India
5.3.1.3 Japan
5.3.1.4 South Korea
5.3.1.5 Rest of Asia-Pacific
5.3.2 North America
5.3.2.1 US
5.3.2.2 Mexico
5.3.2.3 Canada
5.3.2.4 Rest of North America
5.3.3 Europe
5.3.3.1 Germany
5.3.3.2 UK
5.3.3.3 Italy
5.3.3.4 France
5.3.3.5 Rest of Europe
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East & Africa
5.3.5.1 Saudi Arabia
5.3.5.2 South Africa
5.3.5.3 Rest of Middle East & Africa
6 COMPETITIVE LANDSCAPE
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Anhui Jiahang Carbon Fiber Co. Ltd
6.4.2 Anshan Sinocarb Carbon Fibers Co. Ltd
6.4.3 Awa Paper & Technological Company Inc.
6.4.4 Evertech Envisafe Ecology Co. Ltd
6.4.5 Hangzhou Nature Technology Co. Ltd
6.4.6 HP Materials Solutions Inc.
6.4.7 Jiangsu Tongkang Activated Carbon Fiber Co. Ltd
6.4.8 Kuraray Co. Ltd
6.4.9 Nantong Yongtong Environmental Technology Co. Ltd
6.4.10 OJSC
6.4.11 Osaka Gas Chemicals Co. Ltd
6.4.12 TOYOBO CO. LTD
6.4.13 UNITIKA LTD
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Increasing Application in Protective Clothing
7.2 Growing Application in Natural Gas and Methane Storage
MARKET SEGMENTATION
Raw Material
Synthetic
Pitch-based
PAN-based
Phenolic-based
Viscose-based
Other Synthetics
Natural
Application
Purification
Chemical Separation and Catalysis
Protective Clothing
Medical
Super Capacitors
Other Applications
Geography
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
North America
US
Mexico
Canada
Rest of North America
Europe
Germany
UK
Italy
France
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Activated Carbon Market – Growth, Trends, and Forecast (2019 – 2024)
| Chemical & Materials | Published by: Mordor Intelligence | Market: |
| 170 pages | Published: 28-06-2019 |
- Chemical & Materials
- Mordor Intelligence
- 170 pages
- Published: 28-06-2019
Market Overview
The market for activated carbon is expected to register a CAGR of 6.39% during the forecast period of 2019 – 2024. Major factors driving the market studied are conformance to stringent environmental regulations in water treatment applications in the United States and augmenting prominence for air pollution control (especially mercury removal). Narrower markets due to the increased costs of some grades of activated carbon and threat of substitutes like silica gel and super sand are expected to hinder the growth of the market studied.
Water purification application dominated the market in 2018 and is expected to grow during the forecast period, owing to the use of activated carbon in municipal wastewater treatment and a number of industrial processes.
The rising demand from the food and beverage industry is likely to act as an opportunity in the future.
Asia-Pacific dominated the market across the globe with the largest consumption from the countries, such as China and Japan.
Key Market Trends
Increasing Demand for Water Treatment Application
Water treatment is the largest application of activated carbon. Most of the water treatment filters are made up of granular activated carbon.
It is used for the removal of organic-chemical substances and colorants and reduces trace substances, such as chemicals.
Activated carbon is used as a polishing step to remove dissolved organic and non-biodegradable compounds, following physical and biological pre-treatment processes to remove solids and biological oxygen demand.
Activated carbon removes the impurities from water primarily through surface adsorption. Usage of activated carbon for water purification purposes is also the most cost-efficient point-of-use (POU) water purification devices.
Water treatment applications have a high demand for industrial and water treatment in North America and Western Europe. Increase in industrial manufacturing in Asia-Pacific is another major driver for the increase in the activated carbon demand in this segment.
China to Dominate the Market in Asia-Pacific Region
China is the second largest consumer countries of activated carbon in the world after the United States. Activated carbon is used widely in water treatment, food and beverage, healthcare, automotive industries, and industrial processing.
China’s food and beverage industry is enormous and plays an important role in the country’s economy.
The food and beverage industry is expected to continue to grow because of the increasing middle class population with more purchase power, as well as growing attention on the food safety and quality.
Waste water treatment is mainly because of the coal, steel and iron industries which require fresh water for the day to day activities.
North China has approximately 90% of the country’s coal based industries. Also, North China has less reserves of fresh water, therefore, increasing the demand for waste water technologies which in turn is providing opportunities for the activated carbon market during the forecast period.
Competitive Landscape
The activated carbon market is consolidated. The top five players account for more than 50% of the market share. The major companies for the activated carbon market include Calgon Carbon Corporation, Cabot Corporation, Jacobi Carbons, Ingevity, and Kuraray Co. Ltd.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Conformance to Stringent Environmental Regulations in Water Treatment Applications in the United States
4.1.2 Augmenting Prominence for Air Pollution Control (Especially Mercury Removal)
4.2 Restraints
4.2.1 Narrower Markets Due to Increased Costs of Some Grades of Activated Carbon
4.2.2 Threat of Substitutes Like Silica Gel and Supersand
4.3 Industry Value-Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition
4.5 Regulatory Policies
4.6 Trade Analysis (Import And Export Trends)
4.7 Price Trends
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Powdered Activated Carbons (PAC)
5.1.2 Granular Activated Carbons (GAC)
5.1.3 Extruded or Pelletized Activated Carbon
5.2 Application
5.2.1 Gas Purification
5.2.2 Water Purification
5.2.3 Metal Extraction
5.2.4 Medicine
5.2.5 Other Applications
5.3 End-user Industry
5.3.1 Water Treatment
5.3.2 Food and Beverage
5.3.3 Healthcare
5.3.4 Automotive
5.3.5 Industrial
5.3.6 Other End-user Industries
5.4 Geography
5.4.1 Asia-Pacific
5.4.1.1 China
5.4.1.2 India
5.4.1.3 Japan
5.4.1.4 South Korea
5.4.1.5 Rest of Asia-Pacific
5.4.2 North America
5.4.2.1 US
5.4.2.2 Canada
5.4.2.3 Mexico
5.4.2.4 Rest of North America
5.4.3 Europe
5.4.3.1 Germany
5.4.3.2 UK
5.4.3.3 Italy
5.4.3.4 France
5.4.3.5 Rest of Europe
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East & Africa
5.4.5.1 Saudi Arabia
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East & Africa
6 COMPETITIVE LANDSCAPE
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Ada Carbon Solutions LLC
6.4.2 Albemarle Corporation
6.4.3 Cabot Corporation
6.4.4 Calgon Carbon Corporation
6.4.5 Carbon Activated Corporation
6.4.6 CPL CARBON LINK
6.4.7 Donau Chemie Ag
6.4.8 Evoqua Water Technologies LLC
6.4.9 HAYCARB PVT. LTD
6.4.10 Ingevity
6.4.11 Jacobi Carbons Inc. (Osaka Gas Chemicals Co. Ltd)
6.4.12 Kuraray Co. Ltd
6.4.13 Kureha Corporation
6.4.14 Oxbow Activated Carbon
6.4.15 Prominent Systems Inc.
6.4.16 SILCARBON AKTIVKOHLE GMBH
6.4.17 Veolia Water Technologies
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Rising Demand From Food & Beverage Industry
7.2 Increasing Investment And New Mining Projects In Africa
MARKET SEGMENTATION
Product Type
Powdered Activated Carbons (PAC)
Granular Activated Carbons (GAC)
Extruded or Pelletized Activated Carbon
Application
Gas Purification
Water Purification
Metal Extraction
Medicine
Other Applications
End-user Industry
Water Treatment
Food and Beverage
Healthcare
Automotive
Industrial
Other End-user Industries
Geography
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
Italy
France
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Active and Intelligent Packaging Market – Growth, Trends and Forecast (2019 – 2024)
| Packaging | Published by: Mordor Intelligence | Market: |
| 100 pages | Published: 14-06-2019 |
- Packaging
- Mordor Intelligence
- 100 pages
- Published: 14-06-2019
Market Overview
The global Active and Intelligent Packaging Market was valued at USD 16.39 billion in 2018, and it is expected to reach a value of USD 24.5 billion by 2024, at a CAGR of 6.78%, during the forecast period (2019 – 2024). The Commission of the European Communities, in 2004, provided the following legal definition of intelligent packaging: intelligent food contact materials and articles that monitor the condition of packaged food or the environment surrounding the food.
The significant pressure on manufacturers to reduce the use of preservatives in food products has increased the importance of packaging across end-user verticals. With supply chains becoming global, longer shelf life is crucial, for the products to reach the intended customers. Globalization has created the demand for products to be transported across the world, without any loss in nutritional values, or change in chemical compositions. The manufacturing and processing units, especially in the food and beverage industry, have their supply chain spread across the globe. It requires them to procure the raw materials, as well as supply them to distributors, in way that is safe, easy to handle, and quick to move across the supply chain.
The primary advantage of active and intelligent packaging solution is its ability to interact with the enclosed product, playing a dynamic role in its preservation and in the process also keep intact the track of tagged information throughout the supply chain. Active packaging, for instance, may change the composition and organoleptic characteristics of food, provided the changes are consistent with the provisions for food. This is a key driver of the market. However, on the flip-side, it also raises issues of contamination, as plastic seepage into foods may lead to health complications.
The increase in counterfeit products, especially in the pharmaceutical and personal care industries in emerging economies, has also compelled companies to use technologies such as RFID during packaging. All these factors account for a substantial rise in the demand for active and intelligent packaging. However, initial capital needed due to higher costs of installation and implementation, and security issues regarding these systems, are challenging the growth of the market.
Scope of the Report
Active packaging usually means having active functions beyond the inert passive containment and protection of the product. Intelligent and smart packaging usually involve the ability to sense or measure an attribute of the product, the inner atmosphere of the package, or the shipping environment.
Key Market Trends
Food End-User Vertical to Account for Significant Share
Going beyond the visual aspect, leading food brands are looking at innovative ways to make their products stand out on the shelf. An emerging packaging technique, which involves the combination of different materials to enhance the multi-sensorial experiences, is gaining popularity in the food packaging industry.
Food organizations are increasingly embracing sensory marketing, which is a strategy focused on the engaging of multiple senses in the consumer environment, where not only the color or shape, but texture, sound, and even the smell of a pack can influence consumer’s purchasing decisions.
The evolution of intelligent packaging systems through the use of sensor technologies, indicators (including freshness, integrity, and time-temperature indicators (TTI)), and radio frequency identification (RFID) has been assessed for potential use in meat and meat products as well.
Quite recently, the NFC Forum partnered with the active and intelligent packaging industry and the wireless power consortium, to bring new, intelligent labels, interactive tags, and time-temperature monitors, using near field communication, to stores. With this intelligent packaging, consumers can read about food before purchasing, without having to scan anything at all.
United States to Account for Largest Share
The United States is witnessing a rapid rise in its existing population, primarily due to the work-related migrations into the country. This rising population has directly burdened the food industry and affected the packaging industry. It is home to the busiest markets and forms a major part of the workforce dependent on the frozen foods and packaged food for appetite
The pharmaceutical industry is a major segment, which has a vital role to play in the active and intelligent packaging market in the United States. The spending on medicines in the country rose from USD 316 billion in 2010 to USD 450 billion in 2016. Also, the country accounts for more than a quarter of the total pharmaceutical industry, which has critical importance for active and intelligent packaging.
Companies in the country, such as VerifyMe, Inc. entered into a reseller agreement with eAgile. Under this agreement, eAgile will be able to offer its clients VerifyMe’s RainbowSecure Ink Identifier Serialization Technology.
Companies in the country are also entering into strategic mergers and acquisitions to gain a competitive edge. For instance, Resource Label Group, a service provider of pressure sensitive label, shrink sleeve, and RFID/NFC technology for the packaging industry acquired Best Label Company to broaden its west coast presence and position in the label and packaging industry.
Competitive Landscape
The Active and Intelligent Packaging Market is highly fragmented with many players competing in the same space. The unstructured nature of the industry with very few major players involved implies that there is a high rivalry between the smaller companies. Smaller firms are on the rise, with intentions of capturing the high growth potential of the market studied. The market studied can be characterized by intense competition, moderate levels of product differentiation, and high barriers to exit. Brand identity plays a major role in shaping consumer decisions in the market, as strong brands are considered to be synonymous with high-performance and quality. Some of the key players in the market include BASF, Amcor Ltd, Honeywell International Inc. Some of the key developments in Active and Intelligent Packaging Market are as follows:
BASF worked with Zhuhai Fucheng Science and Technology Co., Ltd, one of the major producers of retort pouch and food packaging in China to develop a food cooking bag supporting efficient production. The bag can withstand high temperatures of disinfection, with excellent steam blocking performance. As no solvent is required in the production process, it can realize zero solvent emissions as well as no solvent residue in the packing.
Landec Corporation acquired of Yucatan Foods. With this acquisition of Yucatan Foods help to enable the Landec Natural Foods to grow, strengthen, and stabilize its position in the natural foods market. By creating critical mass in the LNF to better position Landec to evaluate long-term strategies for the company’s two business segments, in order to maximize the shareholder value.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Longer Shelf Life And Changing Consumer Lifestyles
4.3.2 Growing Demand for Fresh and Quality Food Products
4.3.3 Demand for Longer-lasting and Sustainable Packaging Products
4.3.4 Countering Sales of Counterfeit and Imitated Products
4.4 Market Restraints
4.4.1 Issues with the Effects of Packaging Materials on the Human Body
4.4.2 High Initial Capital Investment and Installation Costs
4.4.3 Security and Privacy Issues in the Case of Intelligent Packaging
4.5 Value Chain Analysis
4.6 Industry Attractiveness Porters Five Force Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Active Packaging
5.1.2 Intelligent Packaging
5.2 By End-user Vertical
5.2.1 Food
5.2.2 Beverage
5.2.3 Healthcare
5.2.4 Personal Care
5.2.5 Other End-user Verticals
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 South Korea
5.3.3.5 Rest of Asia-Pacific
5.3.4 Latin America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East and Africa
5.3.5.1 UAE
5.3.5.2 Saudi Arabia
5.3.5.3 South Africa
5.3.5.4 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BASF SE
6.1.2 Amcor Ltd.
6.1.3 Honeywell International Inc.
6.1.4 Landec Corporation
6.1.5 Bemis Company Inc.
6.1.6 Crown Holdings Inc.
6.1.7 Ball Corporation
6.1.8 Sonoco Products Company
6.1.9 Graphic Packaging International LLC
6.1.10 Timestrip UK Ltd
6.1.11 Coveris Holdings SA
6.1.12 Sealed Air Corporation
6.1.13 Dessicare Inc.
6.1.14 WestRock Company
7 INVESTMENT ANALYSIS
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Active Packaging
Intelligent Packaging
By End-user Vertical
Food
Beverage
Healthcare
Personal Care
Other End-user Verticals
Geography
North America
US
Canada
Europe
Germany
UK
France
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of South America
Middle East and Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East and Africa
Active Data Warehousing Market – Growth, Trends and Forecasts (2019 – 2024)
| Information & Communications Technology | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 11-06-2019 |
- Information & Communications Technology
- Mordor Intelligence
- 115 pages
- Published: 11-06-2019
Market Overview
The global active data warehousing market was valued at USD 5.67 billion in 2018 and is expected to reach a value of USD 10.75 billion by 2024, at a CAGR of 11.17% over the forecast period (2019-2024). In recent years, due to rising concerns on data manageability and increasing complexity, data warehousing has attracted significant interest in real-life applications, especially in finance, business, healthcare, and other industries.
The increased need for quick business decisions and growing competition have augmented the importance of business intelligence and real-time data analytics dramatically, which are dependent on real-time date warehousing solutions.
The increasing dependency on big data analytics and business intelligence solutions has predominantly increased the need for more sophisticated data warehousing developers and administrators.
Scope of the Report
Active data warehouse is a repository of any form of captured transactional data so that they can be used for the purpose of finding trends and patterns to be used for future decision making. An active data warehouse has a feature that can integrate data changes while maintaining batch or scheduled cycle refreshes.
Key Market Trends
Hybrid Deployment Expected to Witness Rapid Growth
Although most companies benefit significantly by deploying a cloud-based data warehouse as it is cost-effective, quick to set up, and instantly scalable, companies that require total control, flexibility, accessibility, and predictability might find that an on-premise solution is a better fit for their needs.
If organizations are unsure of choosing the best model fit for their needs, they opt for a hybrid approach, storing their data in an on-premise data center and using the cloud for data processing and analytics. Alternatively, they can store the data in a cloud data warehouse and perform analytics on-premise as well.
The suitable solution for this would be to implement a hybrid approach, where the internal systems can be protected by secret server on-premise and cloud services can be protected on the secret server cloud.
Another compelling reason behind adopting the hybrid model is that investment organizations have already settled into on-premise hardware and software. Software and hardware infrastructure is expensive, and organizations may be unwilling to abandon those capital expenditures, just to move to the cloud. Rather than migrating to the cloud infrastructure entirely, the best possible alternative will be to inherit the hybrid model and make the maximum use of both models.
Canada Anticipated to Witness Rapid Adoption
With the United States being its closest neighbor and the most significant market for cloud computing, Canada has had a considerable advantage in advanced technology transfer. Barring specific data transfer and privacy issues, the cloud computing market in Canada projects a bright picture. Canada has been at the forefront of implementing innovative technologies related to the IT industry, which is one of the fastest growing sectors of the country’s economy.
The market environment for cloud computing continues to develop, as the availability and usage of cloud-based solutions become more prevalent. Almost all enterprises are looking for a solution to reduce the time taken to search for data and improve the efficiency of the employees and organizations. This has increased the utilization of data warehousing solutions, thereby increasing the efficiency of business processes.
Growth is mainly because various SMEs are increasing their investments in IT products and services. Government agencies are also increasing their spending on cloud-based services, as a part of cost-cutting initiatives.
Cloud-based data warehousing acts as an infrastructure design with a higher potential than traditional data warehouse deployment methods. Thus, organizations can use their private cloud for supporting their data warehouse and analytics. Budget constraints for IT, insufficient time to build in-house software, and cost advantages attached to hosted or on-demand software subscriptions are the primary factors responsible for the increased adoption of cloud-based data warehousing solutions by enterprises.
Competitive Landscape
The active data warehousing market is highly fragmented. It comprises of several global and regional players in a fairly-contested market space. However, the market is shifting toward the consolidation of various smaller players.
Sustainable competitive advantage can be gained through innovation. New markets, such as big data or the internet of things, are reshaping the industry trends. This market is characterized by growing levels of product penetration, moderate/high product differentiation, and high levels of competition.
Some of the key players include Oracle, Microsoft, and HP. Some of the key recent developments in the area include:
Oracle launched an autonomous cloud database capable of patching cybersecurity weaknesses on its own accord, according to an announcement by CTO and Chairman Larry Ellison, at Oracle OpenWorld 2017. Oracle Autonomous Database Cloud uses machine learning to eliminate human maintenance and error, offering self-driving, self-scaling, and self-repairing database functions.
Hewlett Packard Enterprise announced the HPE Privileged Account Management (PAM) Service offering, an extension to its HPE Managed Security Services (MSS) portfolio. In partnership with account security software provider CyberArk, this offering is designed to help customers more effectively mitigate the heightened risk associated with privileged accounts, enforce more consistent application of security policies, and reduce manual efforts and administrative costs.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Increase in Adoption of Business Intelligence and Big Data Analytics Solutions in Various Industries
4.4 Market Restraints
4.4.1 High Consumption of Resources and Time Required for Implementation
4.5 Value Chain Analysis
4.6 Industry Attractiveness Porter’s Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type of Deployment
5.1.1 On-premise
5.1.2 Cloud-based
5.1.3 Hybrid
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Spain
5.2.2.5 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Singapore
5.2.3.5 Australia
5.2.3.6 Rest of Asia-Pacific
5.2.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Vendor Market Share
6.2 Company Profiles
6.2.1 ORACLE CORPORATION
6.2.2 HEWLETT PACKARD ENTERPRISE CO
6.2.3 MICROSOFT CORPORATION
6.2.4 SAP SE
6.2.5 AMAZON WEB SERVICES INC
6.2.6 Tresure Data Inc.
6.2.7 Cloudera Inc.
6.2.8 Snowflake Computing Inc.
6.2.9 Pivotal Software, Inc.
6.2.10 Huawei Technologies Co. Ltd
6.2.11 Teradata Corporation
6.2.12 Kognitio Ltd
6.2.13 IBM Corporation
7 MARKET INVESTMENT ANALYSIS
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type of Deployment
On-premise
Cloud-based
Hybrid
Geography
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Singapore
Australia
Rest of Asia-Pacific
Rest of the World
Active Pharmaceutical Ingredients (API) Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 24-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 24-06-2019
Market Overview
The global active pharmaceutical ingredients market was valued at USD 165.74 billion in 2018 and is estimated to reach USD 236.7 billion in 2024, witnessing a CAGR of 6.1%. Some of the key factors that are driving the market include the increasing prevalence of infectious diseases, cardiovascular conditions, and other chronic disorders. Apart from these diseases, genetic disorders are significantly driving the usage of biologicals and biosimilars, globally.
Biosimilars, in many instances, serve as low-cost options. They hold the potential to create a more sustainable healthcare system by making room for innovation so that more patients continue to receive the best possible care.
The active pharmaceutical ingredients (API) market has traditionally been dominated by drugs, such as anti-infectives and diabetes, cardiovascular, analgesics, and pain management drugs. However, as per the R&D trends, the demand is shifting toward the development of complex APIs used in novel formulations, targetting niche therapeutic areas.
A large number of drugs are in the pipeline to develop treatments for cancer, an autoimmune disorder, and metabolic diseases. Owing to the rising prevalence of cancer, several manufacturers are venturing into the development of highly potent APIs (HPAPI) and specialty APIs, in order to cater to the rising demand for these products.
Scope of the Report
Active pharmaceutical ingredient (API) is a part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. They are produced using highly technological industrial processes, both during the R&D and the commercial production phase.
Key Market Trends
Cardiology is Expected to hold the Largest Market Share in the Application Category
The API market, by application, is dominated by the cardiology segment, due to the vast population using various CVD drugs. This segment is projected to witness a CAGR of 6.05% during the forecast period.
Coronary heart disease (CHD) is the most common type of cardiac disease, with a death toll of over 370,000 people, annually, in the United States alone. According to the American Heart Association (AHA), cardiovascular disease accounts for 17.3 million deaths per year. The Centre for Disease Control and Prevention states that about 610,000 people die of heart diseases in the United States every year, i.e., one in every four deaths can be attributed to cardiovascular diseases (CVDs).
Cholesterol reducers and blood pressure lowering drugs are the key drug classes under CVS. Cholesterol reducers, especially Statins, are driving the CVS segment, and have emerged as the most important family of drugs among the cholesterol and triglycerides reducers. Healthcare spending for hypertension was USD 23 to 26 billion in 2017, in the developed markets alone. Another USD 14 to 17 billion was spent in 2017 in the pharmerging markets. The high expenditure on the cardiovascular category highlights the rising demand for APIs in the same.
North America Dominates the Market and is expected to continue its dominance through the Forecast Period
North America currently dominates the market for active pharmaceutical ingredients and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increasing incidences of disease and rising aging population. The United States holds the majority of the market in the North American region. However, the majority of its API requirements are met through imports from the Asian Markets. The trade statistics suggest that nearly 75% to 80% of the APIs imported to the United States are from China and India, as these countries have well-established manufacturing facilities and an abundant talent pool serving the pharmaceutical sector.
The recent political and trade policies implemented by the US government to increase import duties and taxes are expected to drive operational costs and increase the pricing pressure on the manufacturers. The FDA has also increased the application fees for new drug approvals and has increased the number of periodic inspections conducted on various off-share contract manufacturing facilities to ensure the supply of high-quality products to the US market.
Competitive Landscape
The active pharmaceutical ingredients market is highly competitive, and consists of several major players; thus, indicating a fragmented market scenario. The API market has several manufacturers from China and India holding a dominant market position, due to their large manufacturing footprints. In Europe, Italy, Germany, and the United Kingdom are the key regions for API trade, due to the presence of a well-developed pharmaceutical and life sciences industry.
A majority of the APIs produced by reputed MNCs are used for captive production. However, few players have emerged as contract manufacturers with a diversified client base. Further, with increasing technological advancements and product innovation, mid-size and small-scale companies are increasing their market presence, by introducing new ingredients with competitive prices. Companies, like Teva, Pfizer, Aurobindo, Sun Pharmaceuticals, Novartis, Mylan, and Boehringer Ingelheim, hold substantial market shares in the active pharmaceutical ingredients market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Infectious, Genetic, Cardiovascular, and Other Chronic Disorders
4.2.2 Increasing Adoption of Biologicals and Biosimilars
4.2.3 Rising Prevalence of Cancer and Increasing Sophistication in Oncology Drug Research
4.3 Market Restraints
4.3.1 Drug Price Control Policies Across Various Countries
4.3.2 High Competition Between the API Manufacturers
4.3.3 Stringent Regulations
4.4 Industry Attractiveness Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Business Mode
5.1.1 Captive API
5.1.2 Merchant API
5.2 By Synthesis Type
5.2.1 Synthetic
5.2.2 Biotech
5.3 By Type
5.3.1 Generic
5.3.2 Branded
5.4 By Application
5.4.1 Cardiology
5.4.2 Pulmonology
5.4.3 Oncology
5.4.4 Ophthalmology
5.4.5 Neurology
5.4.6 Orthopedic
5.4.7 Other Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aurobindo Pharma
6.1.2 Teva Pharmaceutical Industries Ltd
6.1.3 Pfizer Inc.
6.1.4 Novartis AG
6.1.5 BASF SE
6.1.6 Boehringer Ingelheim GmbH
6.1.7 Dr. Reddy’s Laboratories Ltd
6.1.8 Lupin Ltd
6.1.9 Mylan NV
6.1.10 Sun Pharmaceutical Industries Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Business Mode
Captive API
Merchant API
By Synthesis Type
Synthetic
Biotech
By Type
Generic
Branded
By Application
Cardiology
Pulmonology
Oncology
Ophthalmology
Neurology
Orthopedic
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 151 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 151 pages
- Published: 02-11-2019
The global active pharmaceutical ingredients market was worth US$ 176.3 Billion in 2018. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as “excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the market value is projected to reach US$ 247.2 Billion by 2024, exhibiting a CAGR of 5.8% during 2019-2024.
Market Summary:
Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.
Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.
Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.
Based on the therapeutic application, the market has been segmented as oncology, cardiovascular disease, diabetes, central nervous system and neurological disorders, endocrinology and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.
Key Questions Answered in This Report:
- How has the global active pharmaceutical ingredients market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global active pharmaceutical ingredients industry?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of drug type?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of type of manufacturer?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of synthesis?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of therapeutic application?
- What are the various stages in the value chain of the global active pharmaceutical ingredients market?
- What are the key driving factors and challenges in the global active pharmaceutical ingredients market?
- What is the structure of the global active pharmaceutical ingredients market and who are the key players?
- What is the degree of competition in the global active pharmaceutical ingredients market?
- How are active pharmaceutical ingredients manufactured?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Active Pharmaceutical Ingredients Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Drug Type 5.4 Market Breakup by Type of Manufacturer 5.5 Market Breakup by Type of Synthesis 5.6 Market Breakup by Therapeutic Application 5.7 Market Breakup by Region 5.8 Market Forecast 5.9 SWOT Analysis 5.9.1 Overview 5.9.2 Strengths 5.9.3 Weaknesses 5.9.4 Opportunities 5.9.5 Threats 5.10 Value Chain Analysis 5.11 Porters Five Forces Analysis 5.11.1 Overview 5.11.2 Bargaining Power of Buyers 5.11.3 Bargaining Power of Suppliers 5.11.4 Degree of Competition 5.11.5 Threat of New Entrants 5.11.6 Threat of Substitutes 5.12 Price Analysis 5.12.1 Price Indicators 5.12.2 Price Structure 5.12.3 Margin Analysis 6 Market Breakup by Drug Type 6.1 Innovative Active Pharmaceutical Ingredients 6.2 Generic Active Pharmaceutical Ingredients 7 Market Breakup by Type of Manufacturer 7.1 Captive Manufacturers 7.2 Merchant API Manufacturers 7.2.1 Innovative Merchant API Manufacturers 7.2.2 Generic Merchant API Manufacturers 8 Market Breakup by Type of Synthesis 8.1 Synthetic Active Pharmaceutical Ingredients 8.1.1 Market Breakup by Type 8.1.1.1 Innovative Synthetic APIs 8.1.1.2 Generic Synthetic APIs 8.2 Biotech Active Pharmaceutical Ingredients 8.2.1 Market Breakup by Type 8.2.1.1 Innovative Biotech APIs 8.2.1.2 Biosimilars 8.2.2 Market Breakup By Product 8.2.2.1 Monoclonal Antibodies 8.2.2.2 Vaccines 8.2.2.3 Cytokines 8.2.2.4 Fusion Proteins 8.2.2.5 Therapeutic Enzymes 8.2.2.6 Blood Factors 8.2.3 Market Breakup By Expression System 8.2.3.1 Mammalian Expression Systems 8.2.3.2 Microbial Expression Systems 8.2.3.3 Yeast Expression Systems 8.2.3.4 Plant Expression Systems 8.2.3.5 Insect Expression Systems 9 Market Breakup by Therapeutic Application 9.1 Oncology 9.2 Cardiovascular Disease 9.3 Diabetes 9.4 Central Nervous System and Neurological Disorders 9.5 Endocrinology 9.6 Others 10 Market Breakup by Region 10.1 North America 10.2 Europe 10.3 Asia Pacific 10.4 Middle East and Africa 10.5 Latin America 11 Manufacturing Process 11.1 Product Overview 11.2 Raw Material Requirements 11.3 Manufacturing Process 11.4 Key Success and Risk Factors 12 Competitive Landscape 12.1 Market Structure 12.2 Key Players 12.3 Profiles of Key Players 12.3.1 Pfizer, Inc. 12.3.2 Novartis International AG 12.3.3 Sanofi 12.3.4 Boehringer Ingelheim 12.3.5 Bristol-Myers Squibb 12.3.6 Teva Pharmaceutical Industries Ltd. 12.3.7 ELI Lilly and Company 12.3.8 GlaxoSmithKline 12.3.9 Merck & Co., Inc. 12.3.10 Abbvie Inc. |
Market Breakup by Drug Type
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Market Breakup by Type of Manufacturer
Captive Manufacturers
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Market Breakup by Type of Synthesis
Synthetic Active Pharmaceutical Ingredients
Market Breakup by Type
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients
Market Breakup by Type
Innovative Biotech APIs
Biosimilars
Market Breakup By Product
Monoclonal Antibodies
Vaccines
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
Market Breakup By Expression System
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Plant Expression Systems
Insect Expression Systems
Market Breakup by Therapeutic Application
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Others
Market Breakup by Region
North America
Europe
Asia Pacific
Middle East and Africa
Latin America